RESUMEN
CONTEXT: The transcription factor RAX is a paired-type homeoprotein that plays a critical role in eye and forebrain development of vertebrate species. RAX knockout mice have anophthalmia, cleft palate, and an abnormal hypothalamus and display perinatal lethality. In humans, homozygous or compound heterozygous RAX mutations have been reported to cause bilateral microphthalmia or anophthalmia without consistent associated features. Congenital hypopituitarism can be associated with various eye or craniofacial anomalies; however, the co-occurrence of congenital hypopituitarism, anophthalmia, cleft palate, and diabetes insipidus has been very rare. RESULTS: We report the case of a child with anophthalmia, congenital hypopituitarism, diabetes insipidus, and bilateral cleft lip and palate who had a homozygous frameshift truncating mutation c.266delC (p.Pro89Argfs*114) in exon 1 of the RAX gene. Rax knockout mice show loss of ventral forebrain structures, pituitary, and basosphenoid bone and palate and a misplaced anterior pituitary gland along the roof of the oral cavity. CONCLUSIONS: Our patient's phenotype was more severe than that reported in other patients. Although most of the previously reported patients with RAX mutations showed either a missense or some less severe mutation in at least one of their RAX alleles, our patient was homozygous for truncating mutations that would yield a severe, null protein phenotype. The severity of the genetic defect, the precise match between the knockout mouse and the patient's endocrine phenotypes, and the prominent roles of RAX in eye and pituitary development and diencephalic patterning suggest that the RAX null mutations could fully account for the observed phenotype.
Asunto(s)
Anoftalmos/genética , Labio Leporino/genética , Fisura del Paladar/genética , Diabetes Insípida/genética , Proteínas del Ojo/genética , Proteínas de Homeodominio/genética , Hipopituitarismo/genética , Factores de Transcripción/genética , Animales , Anoftalmos/diagnóstico por imagen , Anoftalmos/patología , Fármacos Antidiuréticos/uso terapéutico , Labio Leporino/diagnóstico por imagen , Labio Leporino/patología , Fisura del Paladar/diagnóstico por imagen , Fisura del Paladar/patología , Desamino Arginina Vasopresina/uso terapéutico , Diabetes Insípida/diagnóstico por imagen , Diabetes Insípida/tratamiento farmacológico , Diabetes Insípida/patología , Mutación del Sistema de Lectura , Terapia de Reemplazo de Hormonas , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Hidrocortisona/uso terapéutico , Hipopituitarismo/diagnóstico por imagen , Hipopituitarismo/tratamiento farmacológico , Hipopituitarismo/patología , Recién Nacido , Imagen por Resonancia Magnética , Masculino , Melatonina , Ratones Noqueados , Hipófisis/anomalías , Tiroxina/uso terapéuticoRESUMEN
Anophthalmia and microphthalmia are among the most common ocular birth defects and a significant cause of congenital blindness. The etiology of anophthalmia and microphthalmia is diverse, with multiple genetic mutations associated with each of these conditions, along with potential environmental causes. Based on findings that mutations in the Rx/Rax homeobox genes in mice and fish lead to defects in retinal development and result in animal models of anophthalmia, we screened 75 individuals with anophthalmia and/or microphthalmia for mutations in the human RAX gene. We identified a single proband from this population who is a compound heterozygote for mutations in the RAX gene. This individual carries a truncated allele (Q147X) and a missense mutation (R192Q), both within the DNA-binding homeodomain of the RAX protein, and we have characterized the biochemical properties of these mutations in vitro. Parents and grandparents of the proband were found to be carriers without visible ocular defects, consistent with an autosomal recessive inheritance pattern. This is the first report of genetic mutations in the human RAX gene.